Multiple Sclerosis: all 3,524 studies
Page 33 of 36. Open to participants first (668), then studies with results posted, then the rest; newest registration first within each.
- Post-Authorization Observational Study to Evaluate Cognition and Fatigue in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Treated With Rebif®CompletedNCT01075880
- An Observational Study to Assess the Quality of Life of the Patients With Multiple Sclerosis and Their CaregiversCompletedNCT01075737
- Improving Gait in Multiple Sclerosis (MS) - Strength Training or Treadmill Walking?CompletedNCT01074827Not applicable
- Study on Cognitive Disorders of Multiple SclerosisCompletedNCT01074619Phase 3
- Tolerability of Rebif® (Interferon-beta 1-A) Therapy in Korean Patients With Multiple SclerosisCompletedNCT01074346
- Neuroprotection and Repair in Optic NeuritisTerminatedNCT01073813Phase 2
- QOLBET Quality Of Life in Patients With Early Relapsing-remitting Multiple Sclerosis Treated With BETaferon® in KoreaWithdrawnNCT01071694
- JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With NatalizumabCompletedNCT01070836
- JC-Virus (JCV) Antibody ProgramCompletedNCT01070823
- Pharmacokinetic, Immunological and Biochemical Sample Collection and Analysis of a Tysabri Patient CohortCompletedNCT01070719
- The Role of Serum Leptin Levels in Multiple Sclerosis Disease Activity While on Interferon Beta 1a (Rebif) TreatmentCompletedNCT01067573
- Impact Study of 2 Therapeutic Strategy for Aggressive Remitting Multiple SclerosisCompletedNCT01065727Not applicable
- A Single-blinded, Controlled, Multi-centre Study of Effects of Exercise in Participants With Multiple SclerosisCompletedNCT01065090
- Climate Influence on Physiotherapy in Multiple SclerosisCompletedNCT01057719Not applicable
- Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple SclerosisCompletedNCT01056471Phase 1/2
- Pulse ACTH vs. MP for MSCompletedNCT01049451Phase 1
- Sensori-motor Integration Training in Multiple SclerosisCompletedNCT01040117Early Phase 1
- Nanocort in Acute Exacerbation of Relapsing-Remitting Multiple Sclerosis (MS)TerminatedNCT01039103Phase 2
- A Study of Orally Administered BGC20-0134 (Structured Lipid) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)TerminatedNCT01037907Phase 2
- Pharmacogenetic Trial and Long-term Follow-up of the PRISMS Trial (PRISMS-15)CompletedNCT01034644
- Telephone Interview of Patients That Participated in the the Pivotal Betaferon MS Trial.CompletedNCT01031459
- Evaluation of the Positron Emission Tomography (PET) Tracer ZK 6032924 in Patients With Multiple Sclerosis Compared to Healthy VolunteersCompletedNCT01031199Phase 1
- Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological ConditionsTerminatedNCT01028209Phase 1
- Novel Immune Markers in Patients With Multiple SclerosisStatus unknownNCT01026272
- Evaluation of Neural Loss in Multiple Sclerosis and Neuromyelitis Optica Using High Resolution OctStatus unknownNCT01024985
- Safety and Immunologic Effect of Low Dose Versus High Dose Vitamin D3 in Multiple SclerosisCompletedNCT01024777Phase 1
- Exploratory Study to Investigate the Reparative and Regenerative Potential of Alemtuzumab in Relapsing-Remitting Multiple Sclerosis Patients Participating in the CARE MS I and MS II StudiesCompletedNCT01020370
- The Efficacy of Botulinum Toxin in Disabling Multiple Sclerosis (MS) TremorCompletedNCT01018485Phase 3
- Trichuris Suis Ova Therapy for Relapsing Multiple Sclerosis - a Safety StudyCompletedNCT01006941Phase 2
- The Effects of Interferon Beta Combined With Vitamin D on Relapsing Remitting Multiple Sclerosis PatientsTerminatedNCT01005095Phase 4
- The Effects of Ethyl-Alpha-Guanido-Methyl Ethanoate on Skin Reactions From Glatiramer Acetate InjectionsWithdrawnNCT00988988Phase 4
- Effect of Adrenocorticotropin Injection With Weekly Interferon Beta in Patients With Relapsing Remitting Multiple Sclerosis (MS)WithdrawnNCT00986960Phase 2
- Efficacy and Safety of Methylprednisolone Per os Versus IV for the Treatment of Multiple Sclerosis (MS) RelapsesStatus unknownNCT00984984Phase 3
- Effects of Meditation on Multiple Sclerosis and Peripheral NeuropathyCompletedNCT00981643Not applicable
- A Monocenter, Cross-sectional Study to Compare Different Type of Cognitive Impairment in Multiple Sclerosis Patients and Cerebrospinal Fluid Biomarkers (Beta Amyloid, Total Tau Protein and Tau-phosphorylated Protein).TerminatedNCT00978536Not applicable
- Herbal Therapy for Subcutaneous Injection Site Reactions in Multiple SclerosisCompletedNCT00972062Not applicable
- Evaluation of [18F] FEPPA and PET Imaging as a Marker of Inflammation in Subjects With Neurological ConditionsCompletedNCT00970333Phase 1
- Study Evaluating Betaferons Safety and Tolerability In Pediatric Patients With Multiple SclerosisCompletedNCT00963833
- Efficacy and Safety of the Pain Relieving Effect of Dronabinol in Central Neuropathic Pain Related to Multiple SclerosisCompletedNCT00959218Phase 3
- Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-responding to an Initial 3 Day Course of Intravenous (IV) MethylprednisoloneTerminatedNCT00947895Phase 2/3
- Motivational Interviewing to Increase Physical Activity to Treat Depression in People Aging With MS or SCICompletedNCT00947232Not applicable
- TakeCharge: Telephone Delivered Self-management Intervention for People With Multiple Sclerosis (MS)CompletedNCT00944190Not applicable
- Atorvastatin 40 mg in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Interferon-Beta-1bCompletedNCT00942591Phase 2
- Biomarkers and Response to Natalizumab for Multiple Sclerosis TreatmentCompletedNCT00942214Phase 4
- Vitamin D3 Supplementation and the T Cell Compartment in Multiple Sclerosis (MS)CompletedNCT00940719Not applicable
- Effect of Tysabri in Patients With Relapsing-Remitting Multiple Sclerosis: A Follow-up Magnetization Transfer Imaging (MTI) StudyCompletedNCT00937677
- Open, Multicentric, Prospective, Quality of Life Study in Multiple Sclerosis PatientsCompletedNCT00928967
- Rajavtihi Neuronal Adult Stem Cells ProjectWithdrawnNCT00927108Phase 2
- Progression of Cognitive and Physical Symptoms in Multiple SclerosisWithdrawnNCT00922831
- Exploratory Study on the Timing of Multiple Sclerosis (MS) SymptomsTerminatedNCT00919217
- The Neuroprotective Effect of Lamotrigine and Interferon Beta 1a in Patients With Relapsing-Remitting Multiple SclerosisStatus unknownNCT00917839Phase 2
- Patient Satisfaction Study of Single-Use Autoinjector for the Delivery of Pre-Filled Avonex SyringeCompletedNCT00915577Phase 3
- Open-Label Safety Extension Study of AvonexCompletedNCT00915460Phase 4
- Comparison of Campath and Rebif Treatment on Cognition in Multiple Sclerosis (MS)Status unknownNCT00914758
- A Study With IPX056 in Subjects With Spasticity Associated With Multiple SclerosisCompletedNCT00914290Phase 2
- Pharmacodynamic Study to Better Understand the Therapeutic Response and Immunomodulatory Effects of Avonex in Multiple Sclerosis (MS) Patients and Healthy VolunteersCompletedNCT00913666Phase 4
- A Bioequivalence Study of Serum Free Avonex and Serum Containing Avonex in Healthy VolunteersCompletedNCT00913250Phase 1
- Immunogenicity and Safety Study of Serum-Free AvonexCompletedNCT00912860Phase 2
- Optical Coherence Tomography: Glatiramer in Clinically Isolated Syndrome or Early Relapsing Remitting Multiple Sclerosis (MS)Status unknownNCT00910598Phase 4
- Effects of Targeted Lower Extremity Joint Training on Multiple Sclerosis (MS) Gait AbnormalitiesCompletedNCT00906737Not applicable
- Injection Management With Betaferon: Influence on Adherence, Patients Satisfaction and Health Related Outcomes (BETAPATH)CompletedNCT00902135
- BEYOND Pilot StudyCompletedNCT00893217Phase 2
- Effects of Tysabri (BG00002) Over 12 Months on MS Related Fatigue in Participants With RRMSCompletedNCT00884481
- Functional and Physiological Responses to Lokomat Therapy (Pilot Study)CompletedNCT00883142
- Physical Activity and Fatigue in Early Multiple Sclerosis (MS)CompletedNCT00882453
- Physical Disability in Patients Treated With BetaferonCompletedNCT00873340
- Effect of Robot-assisted Training on Foot Drop in Multiple SclerosisCompletedNCT00872053Phase 1/2
- A Study for Patients With Multiple SclerosisTerminatedNCT00870155Phase 2/3
- A Study for Patients With Relapsing Remitting Multiple SclerosisCompletedNCT00869986Phase 2/3
- A Study for Patients With Secondary Progressive Multiple SclerosisCompletedNCT00869726Phase 2/3
- A Randomized Exercise Trial for Wheelchair UsersCompletedNCT00866112Not applicable
- Longitudinal (Weekly) Follow-up of Active Plaques in Multiple Sclerosis With 3 Teslas Multi-modality MRI Using Diffusion, Perfusion, Venography and Proton SpectroscopyCompletedNCT00861172Not applicable
- Differential Immune Effects of NatalizumabCompletedNCT00859482
- Modeling and Treating the Pathophysiology of Demyelination in Multiple SclerosisTerminatedNCT00854750Phase 4
- Low Fat Diet and Multiple SclerosisCompletedNCT00852722Phase 1
- Study of Darifenacin in Patients Suffering From Multiple Sclerosis and Neurogenic Detrusor OveractivityTerminatedNCT00845338Phase 2
- The Effectiveness of Locomotor Therapy Using Robot-Driven Gait Orthosis System in Multiple Sclerosis PatientsCompletedNCT00843128Phase 2
- A 24-Hour Pharmacokinetic Determination of BG00012 After Single-Day Oral Administration in Subjects With MSCompletedNCT00837785Phase 1
- Lokomat Treadmill Training Effects on MS GaitCompletedNCT00835835Not applicable
- Anti-Inflammatory Type II Monocyte Induction by Glatiramer Acetate (Copaxone) Treatment of Multiple SclerosisCompletedNCT00819195
- Therapy Optimization in Multiple Sclerosis (MS)CompletedNCT00819000
- Characteristic Study on Chinese Patients With Multiple SclerosisStatus unknownNCT00818103Not applicable
- A Proof of Concept Study to Evaluate the Effectiveness of Tysabri in Relapsing Remitting Multiple Sclerosis (RRMS) Patient Bladder FunctionCompletedNCT00818038
- Autologous Mesenchymal Stem Cell (MSC) Transplantation in MSCompletedNCT00813969Phase 1
- Regional Cortical Cerebral Quantitative MRI Perfusion Correlation Neurocognition in Multiple SclerosisCompletedNCT00812474
- Efficacy, Safety, and Tolerability of Nerispirdine in Patients With Multiple SclerosisCompletedNCT00811902Phase 2
- Open-lable Extension Study on Safety and Efficacy of Neramexane to Treat Congenital and Acquired NystagmusTerminatedNCT00799942Phase 2
- Sunphenon in Progressive Forms of Multiple SclerosisCompletedNCT00799890Phase 2/3
- Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon TreatmentCompletedNCT00787657
- Can Vitamin D Supplementation Prevent Bone Loss in Persons With Multiple SclerosisCompletedNCT00785473Phase 4
- Mesenchymal Stem Cells for the Treatment of MSCompletedNCT00781872Phase 1/2
- Validation of an Obstacle Course Used in Patients With Muscle TightnessStatus unknownNCT00776048
- Single Oral Doses Study of Nerispirdine on Visual Function in Patients With Multiple SclerosisCompletedNCT00772525Phase 2
- A Proof-of-Concept Study to Correlate Retinal Nerve Fiber Layer Changes in Patients With Multiple Sclerosis Treated With Natalizumab or Interferon Beta 1-aWithdrawnNCT00771043Phase 4
- Lokomat Training Effects on MS Gait AbnormalitiesTerminatedNCT00766272Phase 1/2
- Targeted Lower Extremity Joint TrainingTerminatedNCT00765544Phase 1/2
- Chronotherapy in Acute Multiple Sclerosis (MS) AttackTerminatedNCT00764413Not applicable
- Oral Corticotherapy in Megadoses to Treat Multiple Sclerosis During RelapseCompletedNCT00753792Phase 4
- Magnetic Resonance Imaging (MRI) Follow-up of Macrophagic Infiltration in MS Patients Treated With TysabriTerminatedNCT00752778Phase 4
- A Pharmacokinetic (PK) Study of Natalizumab (Tysabri) at Steady StateCompletedNCT00744679Phase 4